STERIS Statistics
Total Valuation
STERIS has a market cap or net worth of $20.48 billion. The enterprise value is $22.71 billion.
| Market Cap | 20.48B |
| Enterprise Value | 22.71B |
Important Dates
The next estimated earnings date is Wednesday, February 5, 2025, after market close.
| Earnings Date | Feb 5, 2025 |
| Ex-Dividend Date | Nov 19, 2024 |
Share Statistics
STERIS has 98.71 million shares outstanding. The number of shares has decreased by -0.55% in one year.
| Current Share Class | 98.71M |
| Shares Outstanding | 98.71M |
| Shares Change (YoY) | -0.55% |
| Shares Change (QoQ) | -0.17% |
| Owned by Insiders (%) | 0.28% |
| Owned by Institutions (%) | 98.50% |
| Float | 98.33M |
Valuation Ratios
The trailing PE ratio is 34.87 and the forward PE ratio is 21.60.
| PE Ratio | 34.87 |
| Forward PE | 21.60 |
| PS Ratio | 3.85 |
| Forward PS | 3.58 |
| PB Ratio | 3.11 |
| P/TBV Ratio | 46.72 |
| P/FCF Ratio | 30.11 |
| P/OCF Ratio | 18.61 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 17.15, with an EV/FCF ratio of 33.39.
| EV / Earnings | 52.23 |
| EV / Sales | 4.26 |
| EV / EBITDA | 17.15 |
| EV / EBIT | 24.21 |
| EV / FCF | 33.39 |
Financial Position
The company has a current ratio of 2.41, with a Debt / Equity ratio of 0.36.
| Current Ratio | 2.41 |
| Quick Ratio | 1.36 |
| Debt / Equity | 0.36 |
| Debt / EBITDA | 1.72 |
| Debt / FCF | 3.53 |
| Interest Coverage | 7.50 |
Financial Efficiency
Return on equity (ROE) is 9.27% and return on invested capital (ROIC) is 6.22%.
| Return on Equity (ROE) | 9.27% |
| Return on Assets (ROA) | 5.45% |
| Return on Capital (ROIC) | 6.22% |
| Revenue Per Employee | $292,949 |
| Profits Per Employee | $23,918 |
| Employee Count | 18,179 |
| Asset Turnover | 0.49 |
| Inventory Turnover | 3.99 |
Taxes
In the past 12 months, STERIS has paid $157.09 million in taxes.
| Income Tax | 157.09M |
| Effective Tax Rate | 20.94% |
Stock Price Statistics
The stock price has decreased by -5.28% in the last 52 weeks. The beta is 0.83, so STERIS's price volatility has been lower than the market average.
| Beta (5Y) | 0.83 |
| 52-Week Price Change | -5.28% |
| 50-Day Moving Average | 219.11 |
| 200-Day Moving Average | 224.44 |
| Relative Strength Index (RSI) | 38.01 |
| Average Volume (20 Days) | 602,845 |
Short Selling Information
The latest short interest is 937,500, so 0.95% of the outstanding shares have been sold short.
| Short Interest | 937,500 |
| Short Previous Month | 1.03M |
| Short % of Shares Out | 0.95% |
| Short % of Float | 0.95% |
| Short Ratio (days to cover) | 1.33 |
Income Statement
In the last 12 months, STERIS had revenue of $5.33 billion and earned $434.80 million in profits. Earnings per share was $4.37.
| Revenue | 5.33B |
| Gross Profit | 2.31B |
| Operating Income | 937.81M |
| Pretax Income | 550.80M |
| Net Income | 434.80M |
| EBITDA | 1.32B |
| EBIT | 937.81M |
| Earnings Per Share (EPS) | $4.37 |
Balance Sheet
The company has $172.20 million in cash and $2.40 billion in debt, giving a net cash position of -$2.23 billion or -$22.57 per share.
| Cash & Cash Equivalents | 172.20M |
| Total Debt | 2.40B |
| Net Cash | -2.23B |
| Net Cash Per Share | -$22.57 |
| Equity (Book Value) | 6.61B |
| Book Value Per Share | 66.80 |
| Working Capital | 1.13B |
Cash Flow
In the last 12 months, operating cash flow was $1.10 billion and capital expenditures -$420.41 million, giving a free cash flow of $680.11 million.
| Operating Cash Flow | 1.10B |
| Capital Expenditures | -420.41M |
| Free Cash Flow | 680.11M |
| FCF Per Share | $6.89 |
Margins
Gross margin is 43.42%, with operating and profit margins of 17.61% and 8.16%.
| Gross Margin | 43.42% |
| Operating Margin | 17.61% |
| Pretax Margin | 14.09% |
| Profit Margin | 8.16% |
| EBITDA Margin | 24.87% |
| EBIT Margin | 17.61% |
| FCF Margin | 12.77% |
Dividends & Yields
This stock pays an annual dividend of $2.28, which amounts to a dividend yield of 1.10%.
| Dividend Per Share | $2.28 |
| Dividend Yield | 1.10% |
| Dividend Growth (YoY) | 10.10% |
| Years of Dividend Growth | 4 |
| Payout Ratio | 52.13% |
| Buyback Yield | 0.55% |
| Shareholder Yield | 1.65% |
| Earnings Yield | 2.12% |
| FCF Yield | 3.32% |
Analyst Forecast
The average price target for STERIS is $262.50, which is 26.51% higher than the current price. The consensus rating is "Buy".
| Price Target | $262.50 |
| Price Target Difference | 26.51% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 6.59% |
| EPS Growth Forecast (5Y) | 24.36% |
Stock Splits
The last stock split was on August 25, 1998. It was a forward split with a ratio of 2:1.
| Last Split Date | Aug 25, 1998 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
STERIS has an Altman Z-Score of 4.89 and a Piotroski F-Score of 6.
| Altman Z-Score | 4.89 |
| Piotroski F-Score | 6 |